A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.
Saved in:
| Title: | A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma. |
|---|---|
| Authors: | Thomas D; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia., McDonald VM; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia., Thomas G; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Lee J; Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Victoria, Australia., Chung LP; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Peters M; Department of Thoracic Medicine, Concord Hospital, Concord, Australia.; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia., Shukla SD; Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Hamada Y; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Clinical Research Centre for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan., Harvey ES; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia., Fricker M; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia., See H; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; The Thoracic Society of Australia and New Zealand, Sydney, New South Wales, Australia., Sabin Thomas R; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia., Farah CS; Department of Thoracic Medicine, Concord Hospital, Concord, Australia.; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Gillman A; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia., Katelaris CH; School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.; Immunology and Allergy Unit, Campbelltown Hospital, Campbelltown, New South Wales, Australia., Katsoulotos GP; Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.; The University of Notre Dame, Sydney, Western Australia, Australia.; St George Specialist Centre, Kogarah, New South Wales, Australia.; St Vincent's Clinic, Darlinghurst, New South Wales, Australia., Langton D; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.; Department of Thoracic Medicine, Frankston Hospital, Frankston, Victoria, Australia., Middleton PG; Department of Respiratory and Sleep Medicine, Westmead Hospital, Sydney, New South Wales, Australia.; Ludwig Engel Centre for Respiratory Research, The Westmead Institute of Medical Research, Sydney, New South Wales, Australia.; Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia., Reynolds P; Lung Research, University of Adelaide and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia., Rimmer J; Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.; Faculty of Medicine, Notre Dame University, Sydney, Australia., Thien F; Eastern Health and Monash University, Melbourne, Victoria, Australia., Vincent S; Thoracic and Sleep Medicine, Cairns and Hinterland Hospital and Health Service, Cairns, Queensland, Australia., Upham JW; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Gibson PG; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Centre of Excellence in Treatable Traits, Hunter Medical Research Institute, Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia. |
| Source: | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2026 May 27. Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8906443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2222 (Electronic) Linking ISSN: 09547894 NLM ISO Abbreviation: Clin Exp Allergy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
